Zenara Pharma, a fully-owned subsidiary of the city-based Biophore India Pharmaceuticals, on Friday announced that it has launched generic Paxlovid (Nirmatrelvir and Ritonavir) tablets in a combi pack as a treatment option for patients with mild to moderate symptoms of Covid-19. A press release from the drug maker said Zenara Pharma has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market this product last month. The product, which will be sold under the brand name 'Paxzen,' is being manufactured at Zenara's US FDA and EU approved state-of-the-art facility in Hyderabad, it said. Pfizer's Paxlovid has been approved by US FDA for COVID trea
Hence then, the article about zenara pharma launches generic anti viral pills for covid 19 in india was published today ( ) and is available onBusiness Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Zenara Pharma launches generic anti-viral pills for Covid-19 in India )